Skip to main content
    AngelBacked

    CRISPR Therapeutics

    BiopharmaCambridge, Massachusetts, United StatesPost-IPO Debt$957.0M total fundingcrisprtx.com
    Latest funding:$550.0M · Post-IPO Debt (March 11, 2026)

    Angel investors who backed CRISPR Therapeutics

    27 investors in our database backed CRISPR Therapeutics.

    Bali Muralidhar

    Managing Partner, Chief Investment Officer

    Kurt von Emster

    Board Member

    andrew sinclair

    Managing Director

    Vin Miles

    Executive Director

    Genghis Lloyd-Harris

    Senior Advisor

    John Heard

    General Counsel

    Tim Haines

    Chairman and Managing Partner

    Brian Atwood

    Founder, CEO

    Charles Warden

    Managing Director

    Ross Jaffe

    Managing Director

    Joel Drewry

    Principal

    Robin Praeger

    Managing Director/Advisor

    Bill Link

    investor

    Don Milder

    Managing Partner

    Beckie Robertson

    Founder and General Partner

    Barbara Lubash

    Managing Director (Emeritus) and Co-Founder

    Rachel Lane PhD

    Chief Business Officer

    guido magni

    Partner ,Versant Ventures

    Clare Ozawa

    Managing Director

    Brad Bolzon

    Chairman, Managing Director

    Alexander Mayweg

    Managing Director

    Paul Grayson

    Partner

    Fang Ni

    Principal

    Vijay Lathi

    Managing Director

    Craig Slutzkin

    Chief Operating Officer and Chief Financial Officer

    Ron Hunt

    Managing Director

    Tom Woiwode

    Managing Director

    Versant Ventures

    View the full investor list for CRISPR Therapeutics

    Find the right investors for your startup

    Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like CRISPR Therapeutics.

    Search investors